Whole-exome Sequencing and Variant Spectrum in Children with Suspected Inherited Renal Tubular Disorder: the East India Tubulopathy Gene Study
Overview
Authors
Affiliations
Background: Inherited tubulopathies are a heterogeneous group of genetic disorders making whole-exome sequencing (WES) the preferred diagnostic methodology.
Methods: This was a multicenter descriptive study wherein children (< 18 years) with clinically suspected tubular disorders were recruited for molecular testing through WES. Multiplex ligation-dependent probe amplification (MLPA) and Sanger sequencing were done when required. Variants were classified as per American College of Medical Genetics 2015 guidelines and pathogenic (P)/likely pathogenic (LP) variants were considered causative.
Results: There were 77 index cases (male =73%). Median age at diagnosis was 48 months (IQR 18.5 to 108 months). At recruitment, the number of children in each clinical group was as follows: distal renal tubular acidosis (dRTA) = 25; Bartter syndrome = 18; isolated hypophosphatemic rickets (HP) = 6; proximal tubular dysfunction (pTD) = 12; nephrogenic diabetes insipidus (NDI) = 6; kidney stone/nephrocalcinosis (NC) = 6; others = 4. We detected 55 (24 novel) P/LP variants, providing genetic diagnoses in 54 children (70%). The diagnostic yield of WES was highest for NDI (100%), followed by HP (83%; all X-linked HP), Bartter syndrome (78%), pTD (75%), dRTA (64%), and NC (33%). Molecular testing had a definite impact on clinical management in 24 (31%) children. This included revising clinical diagnosis among 14 children (26% of those with a confirmed genetic diagnosis and 18% of the overall cohort), detection of previously unrecognized co-morbidities among 8 children (sensorineural deafness n = 5, hemolytic anemia n = 2, and dental changes n = 1) and facilitating specific medical treatment for 7 children (primary hyperoxaluria n = 1, cystinosis n = 4, tyrosinemia n = 2).
Conclusion: WES is a powerful tool in the diagnosis and management of children with inherited tubulopathies in the Indian population. A higher resolution version of the Graphical abstract is available as Supplementary information.
Next-generation nephrology: part 1-an aid for genetic and genomic testing in pediatric nephrology.
Gupta A, Jayasinghe K, Majmundar A, Mann N, Sinha R, Sampson M Pediatr Nephrol. 2025; .
PMID: 39945861 DOI: 10.1007/s00467-025-06697-2.
Mathew V, Deepthi B, Krishnasamy S, Yadav P, Sravani M, Ramprabhu G Pediatr Nephrol. 2025; .
PMID: 39862309 DOI: 10.1007/s00467-025-06656-x.
A molecular journey on the pathogenesis of primary hyperoxaluria.
Cellini B Curr Opin Nephrol Hypertens. 2024; 33(4):398-404.
PMID: 38602143 PMC: 11139248. DOI: 10.1097/MNH.0000000000000987.
Vaisitti T, Bracciama V, Faini A, Del Prever G, Callegari M, Kalantari S Hum Genomics. 2023; 17(1):10.
PMID: 36782285 PMC: 9926680. DOI: 10.1186/s40246-023-00456-w.
Tozaki T, Ohnuma A, Nakamura K, Hano K, Takasu M, Takahashi Y Genes (Basel). 2022; 13(9).
PMID: 36140757 PMC: 9498419. DOI: 10.3390/genes13091589.